*0011859599
*00520230608123556.0
*007ta
*008220924s2022    no a   e m    00  0 eng
*00901967nam a2200421 c 4500
*019  $bl
*020  $a9788230861349$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999921872700302201
*035  $a(NO-DIMO)a3831a4c-cebb-41d5-b112-86e51ef8ee34
*035  $a(NO-LaBS)16944896(bibid)
*035  $aoai:nb.no:pliktmonografi_000009631
*035  $aoai:nb.no:pliktmonografi_000009631
*040  $aNO-OsNB$bnob$erda
*0410 $aeng$bnob
*060 4$aWC 506
*060 4$aWC 515
*1001 $aHansen, Lena$0(NO-TrBIB)97016986$4aut$_185069100
*24000$aStrategies for improving influenza vaccines$_185069200
*24510$aStrategies for improving influenza vaccines :$binsights from the influenza A H1N1 and SARS-CoV-2 pandemics$cLena Hansen
*264 1$a[Bergen], Norway$bUniversity of Bergen$c2022
*300  $a1 bind (varierende paginering)$billustrasjoner
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2022
*546  $aSammendrag på norsk
*650 2$aCOVID-19$ximmunology$0(DNLM)D000086382Q000276$_203024000
*650 2$aInfluenza A Virus, H1N1 Subtype$ximmunology$0(DNLM)D053118Q000276$_203024100
*650 2$aInfluenza Vaccines$ximmunology$0(DNLM)D007252Q000276$_96858500
*650 2$aNeuraminidase$ximmunology$0(DNLM)D009439Q000276$_203024200
*650 2$aViral Vaccines$ximmunology$0(DNLM)D014765Q000276$_203024300
*655 7$aDoktoravhandlinger$0(uri)https://id.nb.no/vocabulary/ntsf/61$2ntsf$_202811400
*7001 $aHansen, Lene$0(NO-TrBIB)1533887368284$tStrategies for improving influenza vaccines$_185239400
*7102 $aUniversitetet i Bergen$bKlinisk institutt 2$0(NO-TrBIB)13034227$4dgg$4pbl$_10179900
*85641$3Fulltekst$uhttps://www.nb.no/search?q=oaiid:"oai:nb.bibsys.no:999920324497502202"$yNettbiblioteket$zSøke-URL
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999920324497502202$b2022-09-24T02:05:25Z$z999920324497502202
^